Lischalk, Jonathan W.
Blacksburg, Seth
Mendez, Christopher
Repka, Michael
Sanchez, Astrid
Carpenter, Todd
Witten, Matthew
Garbus, Jules E.
Evans, Andrew
Collins, Sean P.
Katz, Aaron
Haas, Jonathan
Funding for this research was provided by:
Accuray (20-00-00-1003866)
Article History
Received: 10 June 2021
Accepted: 24 June 2021
First Online: 9 July 2021
Declarations
:
: This single institutional review of patients treated with SBRT for prostate cancer was approved by the local Institutional Review Board (Study # 00001269).
: Not applicable.
: JWL and SB are paid speakers for Accuray. The remaining authors have no competing interests.